Troubles with getting the COVID-19 vaccination distributed has the European Union displeased with two companies.
The COVID-19 pandemic has swept the world. There isn’t a country on the Earth that hasn’t been affected by the virus in some capacity.
There have almost been 100 million cases of COVID-19 throughout the world, and 2.14 million people have died from the virus. The European Union has been devastated by COVID-19. The virus vaccine gave the EU hope that things would start to improve in the relatively near future.
However, this has not been the case. Pfizer and AstraZeneca haven’t delivered on their promises when it comes to vaccine distributions throughout the European Union, which has the European Union displeased.
AstraZeneca News
AstraZeneca promised the European Union that it would be able to fulfill the order of 300 million vaccines from the company.
The European Union also negotiated a deal where it would have the option to purchase an additional 100 million vaccines.
AstraZeneca recently revealed that it will not be able to satisfy the European Union’s order in the required period. AstraZeneca experienced a manufacturing issue, which has delayed vaccine distributions throughout the union.
The EU supply has been hit hard because the company is experiencing its main manufacturing issue in Europe. EU health commissioner Stella Kyriakides made her dissatisfaction clear to the media on Monday.
The EU has threatened to take legal action against AstraZeneca if the company doesn’t fix the issue.
Pfizer Flaws
Pfizer, which is based out of the United States, also had an issue in its European manufacturing process. The company encountered a problem in its Belgium manufacturing plant, which will affect vaccine distributions throughout Europe.
Pfizer made this announcement on Jan. 15, so AstraZeneca’s manufacturing error was the final straw for health officials in the EU. Pfizer is returning to a normal distribution schedule this week.
Pfizer was able to fix its manufacturing issue swiftly, but the EU can’t afford any wasted time. The Belgium Pfizer plant is still on schedule to produce two billion vaccine doses by the end of 2021.
However, the back-to-back announcements from the drug conglomerates didn’t make EU officials happy during these unprecedented times.
European Union Displeased
The problems have the European Union displeased with both companies. Yet, the AstraZeneca news is expected to devastate the EU if the company can’t fix its manufacturing issues.
The European Union invested a lot of money into vaccine research. The issue is that it isn’t receiving the benefit of this financial investment because of AstraZeneca’s internal issues.
EU leaders implemented a distribution plan, but the delayed vaccines are going to force all the countries to alter their original blueprints. This will prolong the virus in the EU and throughout the world.
Europe isn’t the only continent to think about regarding vaccine delivery delays. Countries throughout the EU are on the top of the list to receive the COVID-19 vaccine.
In addition to these areas, the United States, Canada, China, and other rich countries still need to be vaccinated.
A delay for rich territories will indefinitely affect people in third-world countries, which have been forgotten throughout the COVID-19 recovery process. It will be interesting to see how the EU delay affects the third world in the long run.
Get REAL, UNBIASED coverage of the latest political news from our experts at JAZZ Politics & News. Follow us on Social Media to receive instant updates on the latest changes in political betting odds at JazzSports.ag